Do current response criteria in classical Ph-negative myeloproliferative neoplasms capture benefit for patients

G. Barosi; A. Tefferi; T. Barbui

doi:10.1038/leu.2011.337

Do current response criteria in classical Ph-negative myeloproliferative neoplasms capture benefit for patients

G. Barosi, A. Tefferi, T. Barbui

Hematology

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English (US)
Pages (from-to)	1148-1149
Number of pages	2
Journal	Leukemia
Volume	26
Issue number	5
DOIs	https://doi.org/10.1038/leu.2011.337
State	Published - May 2012

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/leu.2011.337

Cite this

@article{d05dcf9c7a4a4f2fbc40245f1f991647,

title = "Do current response criteria in classical Ph-negative myeloproliferative neoplasms capture benefit for patients",

author = "G. Barosi and A. Tefferi and T. Barbui",

note = "Funding Information: This work was supported by European LeukemiaNet (ELN), an EU-funded consortium (LSHC-CT-2004-503216). The experts participating in the Delphi consensus process were: T Barbui (Bergamo, Italy), G Barosi (Pavia, Italy), F Cervantes (Barcelona, Spain), G Finazzi (Bergamo, Italy), C Harrison (London, UK), JJ Kiladjianian (Paris, France), E Lengfelder (Heidelberg, Germany), R Mesa (Scottsdale, AZ, USA), A Pardanani (Rochester, MN, USA), F Passamonti (Varese, Italy), J Samuelsson (Stockholm, Sweden), A Tefferi (Rochester, MN, USA), AM Vannucchi (Florence, Italy), S Verstovsek (Huston, TX, USA).",

year = "2012",

month = may,

doi = "10.1038/leu.2011.337",

language = "English (US)",

volume = "26",

pages = "1148--1149",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Do current response criteria in classical Ph-negative myeloproliferative neoplasms capture benefit for patients

AU - Barosi, G.

AU - Tefferi, A.

AU - Barbui, T.

N1 - Funding Information: This work was supported by European LeukemiaNet (ELN), an EU-funded consortium (LSHC-CT-2004-503216). The experts participating in the Delphi consensus process were: T Barbui (Bergamo, Italy), G Barosi (Pavia, Italy), F Cervantes (Barcelona, Spain), G Finazzi (Bergamo, Italy), C Harrison (London, UK), JJ Kiladjianian (Paris, France), E Lengfelder (Heidelberg, Germany), R Mesa (Scottsdale, AZ, USA), A Pardanani (Rochester, MN, USA), F Passamonti (Varese, Italy), J Samuelsson (Stockholm, Sweden), A Tefferi (Rochester, MN, USA), AM Vannucchi (Florence, Italy), S Verstovsek (Huston, TX, USA).

PY - 2012/5

Y1 - 2012/5

UR - http://www.scopus.com/inward/record.url?scp=84860786173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860786173&partnerID=8YFLogxK

U2 - 10.1038/leu.2011.337

DO - 10.1038/leu.2011.337

M3 - Letter

C2 - 22105597

AN - SCOPUS:84860786173

SN - 0887-6924

VL - 26

SP - 1148

EP - 1149

JO - Leukemia

JF - Leukemia

IS - 5

ER -

Do current response criteria in classical Ph-negative myeloproliferative neoplasms capture benefit for patients

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this